Sungkyunkwan University School of Medicine | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

539,555 results for “Sungkyunkwan University School of Medicine”

Trials

View all 487581 →

Active, not recruiting

The Indications of First Molar Extraction at Tufts University, School of Dental Medicine

240 participants · First posted Jan 12, 2021

Effect of Lidocaine Patch for Shoulder Pain in Laparoscopic Cholecystectomy

63 participants · First posted Jul 11, 2016

A Comparison of McGrath MAC Videolaryngoscopy and Macintosh Laryngoscopy for Orotracheal Intubation in Children With Torticollis

30 participants · First posted Jul 11, 2018

Drugs

View all 6059 →

PittCoVacc

225-Ac-anti-VLA-4 antibody (Johns Hopkins University School of Medicine)

HPC (Cord Blood, Duke University School of Medicine)

Organizations

View all 5009 →

Keio University School of Medicine

Japan

Tokai University School of Medicine

Japan

Tohoku University School of Medicine

Japan

News

View all 40906 →

OpenABE Gene Editor Achieves Up to 36-Fold Efficiency Gain, Overcoming AI-Designed Editor Limitations

Savolitinib Plus TAGRISSO® Shows 56% Response Rate in MET-High Lung Cancer, HUTCHMED Reports

LEAP-014 Trial Shows Lenvatinib Triple Combination Fails to Improve Survival in Metastatic Esophageal Cancer

Page 1 of 53956